Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Advanced Metastatic Gastric Cancer × apatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 4 Ovarian Neoplasms 3 Stomach Neoplasms 2 Solid Tumor 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Two Different Treatment Methods 1 Squamous Cell Carcinoma of Head and Neck 1 Osteosarcoma 1 Mucosal Melanoma 1 Melanoma 1 Immunotherapy Gastrict Cancer 1 Immunotherapy 1 HER-2 Negatived Gastric Cancer 1 Gastric Adenocarcinoma 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1 Advanced Triple Negative Breast Cancer 1 Advanced Metastatic Gastric Cancer 1 Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1 Advanced Gastric Cancer 1 Advanced Gastric Adenocarcinoma 1 Advanced Esophagus Cancer 1 Adenocarcinoma of Lung 1

Interventions

sintilimab 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04089657 2019-09-13

ASGARD

Fujian Cancer Hospital

Phase 2 Unknown

Gastrointestinal

Advanced Metastatic Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡